Composed of a train of extremely short microsecond pulses of which the duration and the intervals are fully adjustable, this subthreshold treatment mode allows a precise management of the thermal effect on the targeted tissues.
The use of this subthreshold emission mode is the cornerstone of the new SubCydo® glaucoma laser therapy.
Supra 810 provides an intuitive and versatile user interface simplifying glaucoma and retina laser treatments.
Built in a clinically oriented manner, it features 4 different software guided procedures.
SubCydo is a new nondestructive laser procedure.
Based on the transcleral cydophotocoagulation principle, it relies on the 810nm stimulation of the ciliary body, producing the aqueous humor, and the uveosderal pathway, secondary route of the aqueous outflow.
It can be performed thanks to the combined use of the Quantel Medical Supra 810 laser and SubCydo probe.
SubCydo clinical data :
|Laser source:||Solide State Technology|
|Power at tissue up to:||3W|
|Pulse duration:||0.01 s to continuous|
|Aiming beam:||635 - 650 nm|
|Repeat interval:||0.1 - 0.2 - 0.3 - 0.5 - 0.7 s|
|Emission modes:||Single, reapeat, continuous, painting SubLiminalTM mode (duty cycle from 5% to 35%)|
|Size:||14.5 (H) x 33 (L) x 30.7 (P) cm
4.79" (H) x 10.83" (W) x 10.07" (D)
|Weight:||9.5 kg - 21 lbs|
|Cooling:||by Peltier effect|
|Power requirements:||100 to 240 VAC, 350 VA, 50/60 Hz|
19-20 Octubre 2018
Manta, Manabí, Ecuador
Bascom Palmer XXXX Inter-American Course in Clinical Ophthalmology,
November 4th - 7th 2018, Florida
Oct. 27th – 30th, 2018,
McCormick Place Chicago, IL USA